Does neurotrophin receptor TrkC predict good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors?
The TrkC neurotrophin receptor appears to be a powerful independent prognostic factor in PNET and may have a role in patient assignment to risk-based treatment strategies.
Returning to work was explained by both injury severity and personality characteristics. Those who did not work were characterized by low health-related quality of life and poorer trauma-related physical and psychological health.